Misoprostol
14
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.1%
1 terminated out of 14 trials
87.5%
+1.0% vs benchmark
43%
6 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Evening Primorose Oil Versus Misoprostol in Cervical Preparation Before Operative Hysteroscopy
Letrozole Plus Misoprostol Versus Misoprostol Only in Induction of Missed Abortion
Misoprostol Before Caesarean Section
Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women
Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida
Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions
Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage
Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion
A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
Study of Clinic-based Versus Self-use of Medical Abortion Pills
Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy
Misoprostol for Non-Viable Pregnancies